- Report
- January 2024
- 189 Pages
Global
From €6656EUR$7,500USD£5,751GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,109GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,109GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,109GBP
- Report
- February 2023
- 107 Pages
Global
From €6656EUR$7,500USD£5,751GBP
- Report
- February 2023
- 50 Pages
Global
From €3506EUR$3,950USD£3,029GBP
- Report
- January 2022
- 90 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Report
- January 2022
- 70 Pages
Global
From €888EUR$1,000USD£767GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 139 Pages
United States
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 134 Pages
Germany
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 133 Pages
Russia
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 131 Pages
China
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 138 Pages
Japan
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 136 Pages
Turkey
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 128 Pages
Canada
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 140 Pages
France
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 138 Pages
Brazil
From €2662EUR$2,999USD£2,300GBP
- Report
- July 2024
- 128 Pages
Italy
From €2662EUR$2,999USD£2,300GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more